DE19602662C2 - Method for the bioluminometric determination of pyrophosphate - Google Patents
Method for the bioluminometric determination of pyrophosphateInfo
- Publication number
- DE19602662C2 DE19602662C2 DE1996102662 DE19602662A DE19602662C2 DE 19602662 C2 DE19602662 C2 DE 19602662C2 DE 1996102662 DE1996102662 DE 1996102662 DE 19602662 A DE19602662 A DE 19602662A DE 19602662 C2 DE19602662 C2 DE 19602662C2
- Authority
- DE
- Germany
- Prior art keywords
- pyrophosphate
- bioluminometric
- luciferin
- luciferase
- determination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
- G01N21/763—Bioluminescence
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plasma & Fusion (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
Description
Die Erfindung betrifft ein Verfahren zur Anwendung von L-Luciferin in bioluminometrischen Messungen.The invention relates to a method for the use of L-luciferin in bioluminometric Measurements.
Die Emission von Licht im Verlauf einer chemischen Katalyse wird als Bioluminiszenz bezeichnet. In der Gegenwart von Adenosintriphosphat (ATP) katalysiert Luciferase (Firefly luciferase EC.1.13.12.7) die oxydative Decarboxylierung von D-Luciferin zu Oxyluciferin. Diese Reaktion ist mit der Emission von Licht verbunden. Da sich Licht sehr empfindlich messen läßt, wird dieses Verfahren allgemein zur Bestimmung von geringen Mengen ATP benutzt (Gould, S. und Subramani, S. (1988) Analytical Biochemistry, 175, 5-13). Die Hauptanwendung der bioluminometrischen ATP-Messungen ist der Nachweis bakterieller Verunreinigungen (Lebensmittelchemie, Militär) sowie die Analyse biochemischer Reaktionen (biologische und medizinische Forschung) (Kricka, L. (1988) Analytical Biochemistry, 175, 14-21).The emission of light in the course of chemical catalysis is called bioluminescence designated. In the presence of adenosine triphosphate (ATP), luciferase (Firefly luciferase EC.1.13.12.7) the oxidative decarboxylation of D-luciferin to oxyluciferin. This reaction is associated with the emission of light. Because light is very sensitive can be measured, this method is generally used for the determination of small amounts of ATP (Gould, S. and Subramani, S. (1988) Analytical Biochemistry, 175, 5-13). the The main application of the bioluminometric ATP measurements is the detection of bacterial Contaminants (food chemistry, military) as well as the analysis of biochemical reactions (biological and medical research) (Kricka, L. (1988) Analytical Biochemistry, 175, 14-21).
Die Katalyse der Luciferase ist stereospezifisch und eine Lichtemission kann daher nur in Gegenwart von D-Luciferin, nicht aber bei Verwendung von L-Luciferin gemessen werden (Seliger, H., McElroy, W., White, E. und Field, G. (1961) Proceedings of the National Academy of Science, 47, 1129-1134; McElroy, W. und Seliger, H. (1962) Federal Proceedings, 21, 1006-1012). Beide Isomere können synthetisiert werden (Bowie, L. (1978), Methods in Enzymology, Vol. LVII, 15-28). Aufgrund der strukturellen Ähnlichkeit wirkt L- Luciferin als kompetitiver Inhibitor von D-Luciferin. Dieser Umstand wird von kommerziellen "ATP momtoring kits" zur Stabilisierung der Luciferaseaktivität ausgenutzt und stellt gleichzeitig die wichtigste praktische Anwendung von L-Luciferin dar (Lundin, A. (1982) Luminescent Assays: Perspectives in Endocrinology and Clinical Chemistry, Hrsg. Serio, M. und Pazzagli, M., Raven Press, New York).The catalysis of the luciferase is stereospecific and a light emission can therefore only in Presence of D-luciferin, but not when using L-luciferin, can be measured (Seliger, H., McElroy, W., White, E. and Field, G. (1961) Proceedings of the National Academy of Science, 47, 1129-1134; McElroy, W. and Seliger, H. (1962) Federal Proceedings, 21, 1006-1012). Both isomers can be synthesized (Bowie, L. (1978), Methods in Enzymology, Vol. LVII, 15-28). Due to the structural similarity, L- Luciferin as a competitive inhibitor of D-luciferin. This fact is used by commercial "ATP momtoring kits" used to stabilize the luciferase activity and provides at the same time represents the most important practical application of L-luciferin (Lundin, A. (1982) Luminescent Assays: Perspectives in Endocrinology and Clinical Chemistry, Eds. Serio, M. and Pazzagli, M., Raven Press, New York).
Der Erfindung liegt die Aufgabe zugrunde, die Stereospezifität der bioluminometrischen Reaktion zu umgehen und damit den Anwendungsbereich bioluminometrischer Messungen zu erweitern.The invention is based on the problem of the stereospecificity of the bioluminometric Bypassing the reaction and thus increasing the scope of bioluminometric measurements expand.
Diese Aufgabe wird erfindungsgemäß durch die folgenden Verfahrensschritte gelöst:According to the invention, this object is achieved by the following process steps:
- - Luciferase wird mit Adenosintriphosphat, L-Luciferin und Pyrophosphatase präinkubiert, - Luciferase is preincubated with adenosine triphosphate, L-luciferin and pyrophosphatase,
- - durch Zusatz von Pyrophosphat wird die Reaktion getriggert und ein Lichtblitz emittiert, der eine qualitative und quantitative Pyrophosphat-Messung ermöglicht.- the reaction is triggered by adding pyrophosphate and a flash of light is emitted, which enables a qualitative and quantitative pyrophosphate measurement.
Es hat sich überraschend gezeigt, daß nach dem Zusatz von Pyrophosphat zu den präinkubierten weiteren Komponenten ein starker Lichtblitz emittiert wird, der eine qualitative und quantitative luminometrische Messung ermöglicht.It has surprisingly been found that after the addition of pyrophosphate to the preincubated other components emit a strong flash of light, which is a qualitative and allows quantitative luminometric measurement.
Im Rahmen der Erfindung liegt auch die Verwendung des erfindungsgemäßen Verfahrens zur bioluminometrischen Bestimmung von Pyrophosphat.The scope of the invention also includes the use of the method according to the invention for bioluminometric determination of pyrophosphate.
Der Vorteil der Erfindung liegt in der Erweiterung des Meßspektrums bioluminometrischer Messungen. Bei unverändert hoher Empfindlichkeit ist es möglich, eine neue Stoffklasse, Pyrophosphate, zu messen. Analog der bioluminometrischen Adenosintriphosphat-Messung ergibt sich damit die Möglichkeit, durch Kopplung chemischer Reaktionen die Produktion bzw. den Verbrauch von Pyrophosphat zu erfassen. Pyrophosphat entsteht z. B. im Zuge der Aktivierung von Zellen durch Hormone, daneben spielt es eine wichtige Rolle im Prozeß der hormonellen Steuerung der mitochondriellen Aktivität.The advantage of the invention lies in the expansion of the bioluminometric measurement spectrum Measurements. With the same high sensitivity, it is possible to add a new class of substances, Pyrophosphates, measure. Analogous to the bioluminometric adenosine triphosphate measurement This creates the possibility of coupling chemical reactions to increase production or record the consumption of pyrophosphate. Pyrophosphate is formed e.g. B. in the course of Activation of cells by hormones, besides it plays an important role in the process of hormonal control of mitochondrial activity.
Im folgenden wird die Erfindung anhand eines beispielhaften Anwendungsbeispiel beschrieben.The invention is described below using an exemplary application example.
Bezüglich pH, Temperatur und Pufferzusammensetzung erfolgt die Präinkubation von Luciferase mit Adenosintriphosphat (ATP) und L-Luciferin unter Standardbedingungen (wie z. B. in Lembert, N. und Idahl, L.-Å., (1995) Biochemical J., 305, 929-933 dargestellt). Das kontinuierliche Erfassen der Lichtemission ist mit kommerziell erhältlichen Luminometern möglich.With regard to pH, temperature and buffer composition, the preincubation takes place Luciferase with adenosine triphosphate (ATP) and L-luciferin under standard conditions (such as z. B. in Lembert, N. and Idahl, L.-Å., (1995) Biochemical J., 305, 929-933). That continuous detection of light emission is possible with commercially available luminometers possible.
Fig. 1 zeigt anhand einer Lichtemission-Zeit-Kurve den Effekt einer Pyrophosphat-Zugabe auf die Lichtemission von Luciferase. Fig. 1 shows by way of light-emission-time curve the effect of pyrophosphate addition to the light emission from luciferase.
Die offenen Kreise bezeichnen den Reaktionsverlauf, gemessen als Lichtemission, von Luciferase (0,1 µM) in der Gegenwart von Adenosintriphosphat (ATP) (100 µM) und L- Luciferin (1 µM). Zum Zeitpunkt 6 min wird zu dieser Lösung Pyrophosphat (PPi) (50 µM) zugegeben. Das Ausbleiben einer nennenswerten Lichtemission unter diesen Reaktionsbedingungen entspricht dem Stand der Technik. The open circles denote the course of the reaction, measured as light emission, from Luciferase (0.1 µM) in the presence of adenosine triphosphate (ATP) (100 µM) and L- Luciferin (1 µM). At the time of 6 min, pyrophosphate (PPi) (50 µM) is added to this solution admitted. The absence of any significant light emission among these The reaction conditions correspond to the state of the art.
Die durchgezogene Linie bezeichnet den Reaktionsverlauf bei der erfindungsgemäßen Vorgehensweise. Hierbei wird Luciferase (0,1 µM) in der Gegenwart von Adenosintriphosphat (ATP) (100 µM) und L-Luciferin (1 µM) mit Pyrophosphatase (0,2 U/ml) präinkubiert. Zum Zeitpunkt 6 min wird zu dieser Lösung Pyrophosphat (PPi) (50 µM) zugegeben. Der dabei auftretende Lichtblitz ist deutlich erkennbar.The solid line denotes the course of the reaction in the case of the invention Method. Here, luciferase (0.1 µM) is used in the presence of adenosine triphosphate (ATP) (100 µM) and L-luciferin (1 µM) preincubated with pyrophosphatase (0.2 U / ml). To the At 6 min, pyrophosphate (PPi) (50 μM) is added to this solution. The one with it The flash of light that occurs is clearly visible.
Eine Blitzinduktion wurde bereits innerhalb folgender Konzentrationsintervalle gemessen:
A flash induction was already measured within the following concentration intervals:
Sowohl die Pufferzusammensetzung als auch die Konzentrationen der Reaktanden können in weiten Grenzen variiert werden.Both the buffer composition and the concentrations of the reactants can be used in can be varied within wide limits.
Claims (1)
- 1. Luciferase wird mit Adenosintriphosphat, L-Luciferin und Pyrophosphatase präinkubiert,
- 2. durch Zusatz von Pyrophosphat wird die Reaktion getriggert und ein Lichtblitz emittiert, der eine qualitative und quantitative Pyrophosphat-Messung ermöglicht.
- 1. Luciferase is preincubated with adenosine triphosphate, L-luciferin and pyrophosphatase,
- 2. The reaction is triggered by adding pyrophosphate and a flash of light is emitted, which enables a qualitative and quantitative pyrophosphate measurement.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1996102662 DE19602662C2 (en) | 1996-01-26 | 1996-01-26 | Method for the bioluminometric determination of pyrophosphate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1996102662 DE19602662C2 (en) | 1996-01-26 | 1996-01-26 | Method for the bioluminometric determination of pyrophosphate |
Publications (2)
Publication Number | Publication Date |
---|---|
DE19602662A1 DE19602662A1 (en) | 1997-08-07 |
DE19602662C2 true DE19602662C2 (en) | 1999-02-25 |
Family
ID=7783680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE1996102662 Expired - Fee Related DE19602662C2 (en) | 1996-01-26 | 1996-01-26 | Method for the bioluminometric determination of pyrophosphate |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE19602662C2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9620209D0 (en) * | 1996-09-27 | 1996-11-13 | Cemu Bioteknik Ab | Method of sequencing DNA |
GB9626815D0 (en) | 1996-12-23 | 1997-02-12 | Cemu Bioteknik Ab | Method of sequencing DNA |
DE102006054562A1 (en) * | 2006-11-20 | 2008-05-21 | Bayer Healthcare Ag | Method for the detection of pyrophosphate with bioluminescence detection |
-
1996
- 1996-01-26 DE DE1996102662 patent/DE19602662C2/en not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
Chemical Abstracts 117 (1992) 107686g * |
Chemical Abstracts 122 (1995) 27033n * |
Also Published As
Publication number | Publication date |
---|---|
DE19602662A1 (en) | 1997-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3882862T2 (en) | Procedure for extracting ATP. | |
DE69024364T2 (en) | REINFORCED CHEMILUMINESCENCE ASSAY | |
DE2162325C3 (en) | Method for the determination of fatty acid glycerol esters and reagent for carrying out the method | |
DE2660548C2 (en) | Conjugates for a heterogeneous specific binding method for the determination of a ligand in a liquid medium | |
DE69405723T2 (en) | DETECTION OF BIOLOGICAL MATERAL | |
DE69412790T2 (en) | MICROBIOLOGICAL TEST PROCEDURE AND REAGENTS | |
DE69829893T2 (en) | Sterilizationsindikator | |
DE2921975A1 (en) | PROCEDURES AND REAGENTS FOR BIOLUMINESCENCE | |
DE69018567T2 (en) | Method for the detection of microorganisms by using resorufin or orcirufin. | |
DE3003490C2 (en) | ||
EP0030718B1 (en) | Method and reagents for the determination of triglycerides | |
EP0322631B1 (en) | Method and reagent for the determination of peracids | |
DE1959410C3 (en) | Indicator for determining the reduced pyridine coenzymes | |
EP0114267A1 (en) | Test system and method for the determination of NAD(P)H | |
DE3106006C2 (en) | ||
DE19602662C2 (en) | Method for the bioluminometric determination of pyrophosphate | |
EP0008342B1 (en) | Method and reagent for the determination of glutamic oxalacetic transaminase and glutamic pyruvic transaminase | |
DE2512266A1 (en) | METHOD FOR DETERMINATION OF TRIGLYCERIDES AND GLYCEROL | |
DE3104078C2 (en) | Method for determining the pH value inside a cell; 1,4-dibutyryloxy-2,3-dicyanobenzene; 1,4-di (-tert-butyloxycarbonyl-1-alanyloxy) -2-3-dicyanobenzene | |
DE3125667C2 (en) | Method and means for the detection of hydrogen peroxide | |
EP0014898A1 (en) | Test tube for analysis of samples in the clinical field, especially for urine analysis | |
EP0228046B1 (en) | Method of increasing the quantum yield in the oxidation of luminol by peroxide in the presence of peroxidase | |
DE2509156A1 (en) | PROCEDURE FOR DETERMINING THE TOTAL CHOLESTEROL AMOUNT IN A SERUM SAMPLE AND INDIVIDUAL REAGENT FOR CARRYING OUT THIS PROCEDURE | |
DE3873066T2 (en) | METHOD FOR IDENTIFYING SALMONELLA DIRECTLY. | |
EP0350808B1 (en) | Method for detecting substances with hydrolase activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OP8 | Request for examination as to paragraph 44 patent law | ||
D2 | Grant after examination | ||
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |